$2.44 billion growth in travel vaccine market size with 42% contribution from North America

NEW YORK, August 22, 2022 /PRNewswire/ — The latest market analysis report titled Travel Vaccines Market By Disease Type and Geography – Forecast and Analysis 2022-2026 was recently added to the Technavio catalog. Analysts in the report have classified the global travel vaccine market as part of the global pharmaceutical market. Our report provides extensive information on the value chain analysis of the travel vaccine market, which vendors can leverage to gain a competitive advantage during the forecast period. The data available in our Value Chain Analytics segment can help vendors increase costs and improve customer services during the forecast period. One of the key factors driving the growth of the global travel vaccine market is the increase in global travel and migration. Furthermore, changes in the demographic profile of travelers globally is one of the key trends in the travel vaccines market that is expected to positively impact the industry during the forecast period. However, the absence of travel vaccine coverage in many health plans is expected to limit the market growth during the forecast period.

Technavio has announced the latest market research report titled Travel Vaccines Market by Disease Type and Geography: Forecast and Analysis 2022-2026, which has partnered with Fortune 500 companies for over 16 years.

For market scope, value chain analysis and key market dynamics, Read a FREE sample

Travel Vaccines Market Segmentation Highlights

For more information based on segments and regional opportunities, Sample report request

  • The travel vaccine market is fragmented and vendors are deploying growth strategies such as R&D investment to compete in the market. Travel Vaccines Market Forecast Report offers detailed insights into key vendor profiles. The profiles include information on the production, sustainability and outlook of the leading companies.

  • Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc. , Mitsubishi Chemical Holdings Corp., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd. and Valneva SE are some of the main market participants.

  • To take full advantage of opportunities, market vendors should focus more on the growth prospects of fast-growing segments while maintaining their positions in slow-growing segments.

  • Sellers offer a wide range of offers to gain a competitive edge in the market. For example, CSL Ltd. offers the most comprehensive influenza vaccine and a wide range of vaccines and specialty medicines that meet unique local public health needs. Bharat Biotech Ltd. offers travel vaccines such as BioHib, a freeze-dried vaccine used for development from an Indian strain.

  • Backed by competitive intelligence and benchmarking, our travel vaccine market research reports are designed to provide entry support, customer profiling and M&A as well as strategic exit support .

More supplier offerings and their strategic initiatives are available Sample report in PDF

Scope of the travel vaccine market

Technavio presents a detailed picture of the market by studying, synthesizing and aggregating data from multiple sources. Our travel vaccine market report covers the following areas:

Travel Vaccine Market Highlights

  • Market CAGR during the forecast period 2022-2026

  • Detailed information on factors that will aid the growth of the travel vaccine market over the next five years

  • Estimation of the travel vaccine market size and its contribution to the parent market

  • Predictions about upcoming trends and changes in consumer behavior

  • The growth of the travel vaccine market

  • Market competitive landscape analysis and detailed vendor information

  • Comprehensive details of the factors that will challenge the growth of the Travel Vaccine market vendors

Related reports:

Vaccine market by Type and Geography – Forecast and Analysis 2022-2026

Market of human combined vaccines by Type and Geography – Forecast and Analysis 2021-2025

Therapeutic Vaccines Market by Type and Geography – Forecast and Analysis 2020-2024

Market of vaccines against foot-and-mouth disease by product and geography – Forecast and analysis 2021-2025

Scope of the travel vaccine market

Coverage of the report

Details

Page number

120

base year

2021

Forecast period

2022-2026

Growth momentum and CAGR

Accelerating with a CAGR of 8.59%

Market growth 2022-2026

2.44 billion dollars

Market structure

fragmented

Year-on-year growth (%)

7.85

Regional analysis

North America, Europe, Asia and Rest of World (ROW)

Realization of the contribution to the market

North America at 42%

Key consumer countries

USA, Germany, UK, Japan and China

Competitive landscape

Leading companies, competitive strategies, scope of consumer participation

Profiled companies

Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc. , Mitsubishi Chemical Holdings Corp., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd. and Valneva SE

Market dynamics

Main market analysis, market growth drivers and obstacles, fast and slow growing segment analysis, impact of COVID-19 and future consumer dynamics and analysis of market conditions for the forecast period.

Customization scope

If our report doesn’t include the data you’re looking for, you can contact our analysts and customize the segments.

Table of contents:

1 Executive summary

2 Market landscape

3 Size of the market

4 Analysis of the five forces

5 Market segmentation by type of disease

6 Customer landscape

7 Geographical Landscape

8 drivers, challenges and trends

9 Landscape of sellers

10 Analysis of suppliers

11 Appendix

About us

Technavio is a world leader in technology research and consulting. His research and analysis focuses on emerging market trends and provides useful information to help companies identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of over 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Its customer base consists of companies of all sizes, including more than 100 Fortune 500 companies. This growing customer base relies on Technavio’s comprehensive coverage, extensive research and actionable market intelligence to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

contact

Search Technavio
Jesse Maida
Media and marketing executive
USA: +1 844 364 1100
United Kingdom: +44 203 893 3200
E-mail: [email protected]
Website: www.technavio.com/

Technavio (PRNewsfoto/Technavio)

Technavio (PRNewsfoto/Technavio)

Cleavage

Cleavage

View original content to download media: https://www.prnewswire.com/news-releases/usd-2-44-billion-growth-in-travel-vaccines-market-size-with-42-of-the-contribution -from-north-america—technavio-301609618.html

SOURCE Technavio

Leave a Comment

Your email address will not be published.